News & Trends - Medical Technology

Abbott’s world-leading glucose technology TGA registered

Health Industry Hub | March 31, 2021 |
[Total: 2    Average: 4.5/5]

MedTech News: Abbott announced its next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2 is now registered for use in Australia by adults and children (4 and older) with insulin-dependent diabetes, subsequent to review by Australia’s Therapeutic Goods Administration (TGA).

FreeStyle Libre 2, now with automated, optional, real-time glucose alarms, will be made available in Australia over the coming months and will be priced the same as the current FreeStyle Libre system, which is at a fraction of the price of other CGMs (Continuous Glucose Monitors).

“Abbott’s next-generation FreeStyle Libre 2 offers an important choice, with its breakthrough technology and the same price as the popular FreeStyle Libre system” said Peter Chalikias, regional director of Abbott’s diabetes care business in ANZ. “This latest technology is designed to simplify a condition that is not without challenges, and is also accessible to as many people living with diabetes as possible in Australia.”

With FreeStyle Libre 2, more Australians can enjoy features such as unsurpassed 14-day accuracy, excellent performance, trends, insights and actionable data with the FreeStyle LibreLink mobile app10 or on a reader, in a fully disposable device.

Abbott’s FreeStyle Libre 2’s new features such as automated, optional, real-time alarms and ability to measure glucose levels every minute give users the option to be alerted in real-time of critical events such as hypoglycemia (low glucose levels4) or hyperglycemia (high glucose levels).

You may also like Market access and funding key barriers to MedTech innovation, says past President of Stryker Asia-Pacific

The wearable technology, which eliminates the need for painful fingersticks, also provides people with diabetes with unsurpassed 14-day accuracy and actionable information to better manage their condition.

Over the coming months, Abbott will work with the Department of Health to advance the process of including the FreeStyle Libre 2 system on the NDSS. The FreeStyle Libre 2 will be priced the same as the FreeStyle Libre system, which is aimed to ensure equitable and affordable access to this next-generation glucose monitoring technology for more Australians.

FreeStyle Libre 2 stock will be available in the coming months.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - The power of being an authentic leader

The power of being an authentic leader

Health Industry Hub | April 21, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]


Digital & Innovation

Healthcare Technology Digital Innovations - Data is the biggest challenge, and opportunity, for MedTech

Data is the biggest challenge, and opportunity, for MedTech

Health Industry Hub | April 21, 2021 |

Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]


News & Trends - Medical Technology

MedTech News - Thermo Fisher acquisition to better serve its pharma and biotech clients

Thermo Fisher acquisition to better serve its pharma and biotech clients

Health Industry Hub | April 21, 2021 |

MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]


News & Trends - Pharmaceuticals

Pharma News - First-in-class oncology drug candidate licensed by Aussie pharma

First-in-class oncology drug candidate licensed by Aussie pharma

Health Industry Hub | April 21, 2021 |

Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]